Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis
Authors:
Open Access
- 8 July 2012
- journal article
- research article
- Published by Springer Nature in Nature Genetics
- Vol. 44 (8) , 886-889
Abstract
Michael Bamshad and colleagues report an exome sequencing study of extreme phenotypes to identify genetic variants that modify the risk for chronic Pseudomonas aeruginosa airway infection in individuals with cystic fibrosis. Exome sequencing has become a powerful and effective strategy for the discovery of genes underlying Mendelian disorders1. However, use of exome sequencing to identify variants associated with complex traits has been more challenging, partly because the sample sizes needed for adequate power may be very large2. One strategy to increase efficiency is to sequence individuals who are at both ends of a phenotype distribution (those with extreme phenotypes). Because the frequency of alleles that contribute to the trait are enriched in one or both phenotype extremes, a modest sample size can potentially be used to identify novel candidate genes and/or alleles3. As part of the National Heart, Lung, and Blood Institute (NHLBI) Exome Sequencing Project (ESP), we used an extreme phenotype study design to discover that variants in DCTN4, encoding a dynactin protein, are associated with time to first P. aeruginosa airway infection, chronic P. aeruginosa infection and mucoid P. aeruginosa in individuals with cystic fibrosis.Keywords
This publication has 19 references indexed in Scilit:
- Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patientsRespiratory Research, 2010
- Early anti-pseudomonal acquisition in young patients with cystic fibrosis: Rationale and design of the EPIC clinical trial and observational study,Contemporary Clinical Trials, 2009
- Dynein-dependent Movement of Autophagosomes Mediates Efficient Encounters with LysosomesCell Structure and Function, 2008
- Evaluating the “Leeds criteria” forPseudomonas aeruginosainfection in a cystic fibrosis centreEuropean Respiratory Journal, 2006
- Longitudinal Development of Mucoid Pseudomonas aeruginosa Infection and Lung Disease Progression in Children With Cystic FibrosisJAMA, 2005
- Automated High-Throughput Sex-Typing AssayBioTechniques, 2004
- Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: A marker of therapeutic success?—A 30‐year Cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infectionPediatric Pulmonology, 2004
- Pathophysiology and Management of Pulmonary Infections in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patientsJournal of Cystic Fibrosis, 2003
- Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosisPediatric Pulmonology, 2002